G-10 GROUP
October 1st, 2001
BY KEITH NUTHALLA CONSULTATION round has been a launched by the so-called G-10 pharmaceuticals group, set up by the European Commission to consider ways of enhancing the industry's competitiveness, whilst safeguarding patient interests.Comments have been requested on a paper, which examines issues such as pricing, information to patients, cost-effectiveness, competitiveness, benchmarking, innovation and generics. Replies are to be fed into a final report and recommendations from the group, to be released next April.The group is looking into how successfully ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.